DUBLIN–(BUSINESS WIRE)–The “Global
Niemann-Pick Disease Clinical Trial Pipeline Highlights – 2019”
report has been added to ResearchAndMarkets.com’s
offering.
Niemann-Pick Disease Pipeline Highlights – 2019 provides most up-to-date
information on key pipeline products in the global Niemann-Pick Disease
market. It covers emerging therapies for Niemann-Pick Disease in active
clinical development stages including early and late stage clinical
trials. The pipeline data presented in this report helps executives for
tracking competition, identifying partners, evaluating opportunities,
formulating business development strategies, and executing in-licensing
and out-licensing deals.
Clinical Trial Stages:
The report provides Niemann-Pick Disease pipeline products by clinical
trial stages including both early and late stage development – phase 3
clinical trials, phase 2 clinical trials, phase 1 clinical trials,
preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Niemann-Pick Disease pipeline products by their
dominant mechanism of action/drug class. This helps executives
categorize products based on their drug class and also assess the
strengths and weaknesses of compounds.
Company:
The report provides Niemann-Pick Disease pipeline products by the
company.
Short-term Launch Highlights:
Find out which Niemann-Pick Disease pipeline products will be launched
in the US and Ex-US till 2024.
Key Topics Covered:
1. Niemann-Pick Disease Pipeline by Stages
2. Niemann-Pick Disease Phase 3 Clinical Trial Insights
3. Niemann-Pick Disease Phase 2 Clinical Trial Insights
4. Niemann-Pick Disease Phase 1 Clinical Trial Insights
5. Niemann-Pick Disease Preclinical Research Insights
6. Niemann-Pick Disease Discovery Stage Insights
7. Appendix
8. Research Methodology
For more information about this report visit https://www.researchandmarkets.com/r/myzod5
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Clinical
Trials, Endocrine
and Metabolic Disorders Drugs